Navigation Links
New Lupus Drug Results From Scripps Research Technology
Date:3/9/2011

Benlysta® (itself a type of immune molecule) acts by targeting a specific protein called B-lymphocyte stimulator, or BLyS, involved in stimulating the "autoantibodies" causing lupus and certain other autoimmune disorders.

Benlysta® is the first approved drug that disables BLyS, thus preventing the immune system's destructive attacks against the body.

The Foundation

In the 1980s the therapeutic potential of antibodies—which recognize a wide range of foreign pathogens, then alert the immune system to the presence of the invaders—was widely recognized, as they are an important part of the body's natural system for fighting illness. But tapping that potential had proven difficult. Researchers at the time were working mainly with short snippets of antibodies and testing their effects through a slow and painstaking petri-dish process.

But Lerner led a Scripps Research team that made two critical advances to transform the field, ultimately leading to the discovery and development of drugs such as Benlysta®.

The researchers first developed a method of combining different pieces of antibodies isolated from human or animal cells into proteins long enough to encompass natural antibodies' most critical portions—the parts actually binding to and neutralizing infectious agents or otherwise unwanted material. The scientists dubbed this technique "repertoire cloning," because it allowed them to build libraries of compounds that encompassed the full repertoire of a natural immune system.

This was a game-changing development.

Eliminating the Petri-Dish Bottleneck

But even with an expansive repertoire, putting it to use was a separate problem. It was a second key Scripps Research discovery that helped eliminate the petri-dish bottleneck.

In the 1989 to 1991 timeframe, Lerner and his colleagues pioneered a technique for employing phage display to facilitate large "comb
'/>"/>

SOURCE The Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
2. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
3. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
10. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
11. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 ... EGFR mutation   is a viable alternative to tumour biopsy ... testing in all patients with advanced NSCLC   ... effectiveness of plasma circulating tumour DNA (ctDNA) testing for epidermal ... with advanced non-small cell lung cancer (NSCLC) in clinical practice. ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has announced ... Global Strategic Business Report" report to their offering. ... Medical Oxygen Systems in US$ Thousands by the following ... Regulators, and Oxygen Conserving Devices. The report provides separate ... , Japan , Europe ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... 2nd edition" report to their offering. ... perspectives from 130 patient groups with an interest in ... companies (and of the pharma industry as a whole) ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... MELVILLE, N.Y., April 23, 2012  Henry Schein, ... provider of health care products and services to dental, ... with the launch of its 2012 Global Reflections program ... "Henry Schein firmly believes that protecting ...
... Systems, Inc. (NASDAQ: DCTH ) today announced it ... revolver with Silicon Valley Bank ("SVB"), a leading provider of ... available for general corporate purposes supporting the overall growth and ... transaction, Eamonn P. Hobbs, President & CEO of Delcath Systems, ...
Cached Medicine Technology:Henry Schein Celebrates Earth Day 2Henry Schein Celebrates Earth Day 3Delcath Systems, Inc. Secures $20 Million Credit Facility 2Delcath Systems, Inc. Secures $20 Million Credit Facility 3Delcath Systems, Inc. Secures $20 Million Credit Facility 4
(Date:4/18/2015)... 18, 2015 More than 2000 styles ... at TheCelebrityDresses.com, the #1 online store carrying celebrity inspired ... girls have got their perfect dresses for their prom. ... fashion prom dresses at TheCelebrityDresses.com would be an ideal ... than 2000 prom dresses inspired by the most loved ...
(Date:4/18/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Therapy Association Annual Conference to be held May ... SC. , The SCAPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:4/18/2015)... 18, 2015 PHOENIX, ARIZONA – In ... with 11 other secure destruction professionals across the United ... (CSDS). He will now display “CSDS” as a professional ... before the National Association of Information Destruction 2015 Annual ... Grapevine, Texas. Of the 20 people who took the ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... NY (PRWEB) April 18, 2015 Rosetta ... their facility, rounding out their list of diagnostic imaging ... center for patients on the Upper East Side of ... running at full capacity. The addition of PET-CT, combined ... their physicians the ability to work with patients through ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... By Amanda Gardner HealthDay Reporter , MONDAY, ... pediatricians is calling for a ban on all junk food ... means of slowing the rising tide of obesity among young ... issue of Pediatrics , the American Academy of Pediatrics ...
... This release is available in German . ... more than one million euros in research and development funding ... at the research neutron source FRM II. In a 2009 ... the high neutron flux the neutron source in Garching can ...
... Hughes Medical Institute, the Max Planck Society and the ... a new, top-tier, open access journal for biomedical and ... establish a new journal that will attract and define ... All research published in the journal will make highly ...
... HealthDay Reporter , SUNDAY, June 26 (HealthDay News) -- ... lose weight, and low-fat diets that are either high in ... researchers say. "I think there are two key messages ... a senior lecturer with the school of medicine and health ...
... illicit drug used by teenagers and adults around the world. ... States report smoking it, and most high schoolers say they ... smoking pot is no big deal. They cite reasons such ... it." Denise Walker, co-director of the University of Washington,s ...
... tested a predatory bacterium Bdellovibrio against ... found that it significantly reduced the numbers of Salmonella ... safe when ingested. The research was funded by ... Professor Liz Sockett,s team at The University of Nottingham, with ...
Cached Medicine News:Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 2Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 3Health News:Cancer diagnosis isotopes from Garching 2Health News:Leading research organizations announce top-tier journal for biomedical and life sciences 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 3Health News:2 talks with teens leads to less marijuana use for at least a year 2Health News:2 talks with teens leads to less marijuana use for at least a year 3Health News:Living antibiotic effective against Salmonella 2
... comfortable lightweight brace is designed for ... ulnar fractures. The anatomically correct design ... compression for optimal control of ulnar ... elbow motion is permitted to prevent ...
... Blue Line Wrist Control offers a custom ... support for Carpal Tunnel Syndrome, tendinitis, sprains, ... wrist. Careful design leaves fingers free for ... Lightweight metal stay can be contoured for ...
... The RCAI Dorsal Blocking Splint is constructed of ... The DBS protects the flexor tendons of the ... prevents scar tissue development in the later stages ... rest dorsally on the hand and positions the ...
Used for fractures of the phalanges where extension is required. Used to immobilize the joint following dislocation. Curved to conform to the finger.Choose from four sizes 1.5", 2.5", 4" and 6". Unpa...
Medicine Products: